AUTH/2559/11/12: Orion Pharma UK – Sponsorship of ISU meeting at 5-star Belfast venue (Clause 9.1 breach) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2559/11/12
Parties	Anonymous group of NHS health professionals v Orion Pharma
Issue	Sponsorship/exhibiting at ISU annual meeting; concerns about excessive hospitality and overall impression (5-star venue; golf and gala dinner referenced in programme)
Meeting	Irish Society of Urology (ISU) annual meeting, Belfast (Northern Ireland), September 2012
Venue	Culloden Estate and Spa, Holywood, Belfast (described as 5-star)
Complainant allegations	Excessive hospitality; undue emphasis on luxury/social aspects; golf/leisure and gala dinner featured
Orion involvement (as stated)	Orion Pharma (Ireland) Ltd paid to register as a trade exhibitor; later confirmed three Orion Ireland personnel attended the conference dinner; no attendance at gala dinner; no delegate sponsorship stated
Applicable Code year	2012
Complaint received	26 November 2012 (HTML case page) / 4 December 2012 (PDF compilation timeline)
Completed	12 February 2013
Appeal	No appeal
Breach findings	Breach Clause 9.1; No breach Clauses 2 and 19.1
Sanctions	Undertaking received; additional sanctions not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

An anonymous, non-contactable group of NHS health professionals complained about excessive hospitality linked to the Irish Society of Urology (ISU) annual meeting held in Belfast (Northern Ireland) in September 2012.
The programme highlighted a “very luxurious” 5-star venue (Culloden Estate and Spa) with photos and local attractions, and included messaging emphasising the “social aspect” of the meeting.
The programme also listed post-meeting leisure/social items (golf and a gala dinner at Stormont/Parliament Buildings) and thanked multiple companies (including Orion) for their support, without clearly stating what each company funded.
Orion’s position: Orion Pharma (Ireland) Ltd paid to register as a trade exhibitor only; Orion said it did not sponsor delegates, did not fund golf or the gala dinner, and its staff left at the end of the scientific programme (though Orion later confirmed three Orion Ireland personnel attended the conference dinner).
The Panel applied the ABPI Code because the meeting took place in Northern Ireland, and noted UK companies can be responsible for overseas affiliates’ activities when carried out in the UK or relating to UK health professionals.

⚖️

⌄

Breach: Clause 9.1
No breach: Clauses 2 and 19.1
The Panel’s key concern was the overall impression created: a 2-day meeting at a luxurious 5-star venue with golf and a gala dinner referenced in the programme, combined with unclear sponsorship declarations that could imply companies supported the full social programme.

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access